中文名 | ST 2825 |
英文名 | ST 2825 |
别名 | 化合物 T16937 (2R,4'R,8'AR)-1-[2-[4-[[2-(2,4-二氯苯氧基)乙酰基]氨基]苯基]乙酰基]四氢-6'-氧代螺[吡咯烷-2,7'(6'H)-[2H]吡咯并[2,1-B][1,3]噻嗪]-4'-甲酰胺 |
英文别名 | ST2825 ST 2825 (2R,4'R,8'aR)-1-[2-[4-[[2-(2,4-Dichlorophenoxy)acetyl]amino]phenyl]acetyl]tetrahydro-6'-oxospiro[pyrrolidine-2,7'(6'H)-[2H]pyrrolo[2,1-b][1,3]thiazine]-4'-carboxamide Spiro[pyrrolidine-2,7'(6'H)-[2H]pyrrolo[2,1-b][1,3]thiazine]-4'-carboxamide, 1-[2-[4-[[2-(2,4-dichlorophenoxy)acetyl]amino]phenyl]acetyl]tetrahydro-6'-oxo-, (2R,4'R,8'aR)- |
CAS | 894787-30-5 |
化学式 | C27H28Cl2N4O5S |
分子量 | 591.51 |
密度 | 1.51±0.1 g/cm3(Predicted) |
沸点 | 939.0±65.0 °C(Predicted) |
溶解度 | 10毫米DMSO |
酸度系数 | 12.86±0.70(Predicted) |
存储条件 | -20℃ |
体外研究 | ST2825 blocks IL-1R/TLR signaling by interfering with MyD88 homodimerization. ST2825 inhibits this interaction in a concentration-dependent manner with ~40% inhibition of dimerization at 5 μM ST2825 and 80% inhibition at 10 μM ST2825. |
体内研究 | ST2825 dose-dependently inhibits IL-1β-induced production of IL-6 in treated mice after oral administration. The animals are administered orally with the appropriate vehicles or ST2825 at doses ranging from 50 to 200 mg/kg, 5 min prior to i.p. injection with 20 μg/kg IL-1β. ST2825 exertes a significant inhibition of IL-1β-stimulated production of IL-6 at 100 and 200 mg/kg. |
上游原料 | FMOC-(4-氨基苯基)乙酸 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.691 ml | 8.453 ml | 16.906 ml |
5 mM | 0.338 ml | 1.691 ml | 3.381 ml |
10 mM | 0.169 ml | 0.845 ml | 1.691 ml |
5 mM | 0.034 ml | 0.169 ml | 0.338 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!